Galapagos CEO says a sale to Gilead is 50% likely

The daily De Telegraaf on Saturday published a statement by Onno van De Stolpe, CEO of Belgium-based biotech Galapagos, according to which the group is 50% likely to be acquired by a competitor over the next 10 years.